Status | Study |
Recruiting |
Study Name: Topical Vitamin D in Acute Graft Versus Host Disease of the Skin Condition: Graft Vs Host Disease Date: 2017-03-23 Interventions: Dietary Supplement: Calcipotriene Topical vitamin D cream will be applied to affected areas of the skin. |
Not yet recruiting |
Study Name: A Study of Obinutuzumab for Prevention of Chronic Graft-vs.-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation Condition: Graft vs. Host Disease Date: 2016-08-11 Interventions: Drug: Obinutuzumab B cell depl |
Recruiting |
Study Name: A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease Condition: Graft vs Host Disease Date: 2015-03-01 Interventions: Biological: Donor regulatory T cell adoptive immunotherapy in chronic graft versus host disease |
Recruiting |
Study Name: A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory Chronic Graft-versus-Host-Disease Condition: Chronic Graft-versus-host-disease Date: 2015-01-07 Interventions: Procedure: Extracorporeal Photopheresis (ECP) |
Recruiting |
Study Name: Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells Condition: Chronic Graft-Versus-Host Disease Date: 2014-11-05 Interventions: Biological: Mesenchymal Stromal Cells Mesenchymal stem cell(MSC). Patients with newly diagnosed cGvHD: p |
Recruiting |
Study Name: Phase II Trial of Natalizumab (Tysabri®) Plus Prednisone for Initial Therapy of Acute Graft Versus Host Disease (aGVHD) of the Gastrointestinal Tract Condition: Graft Versus Host Disease Date: 2014-06-25 Interventions: Drug: Natalizumab Other Name: |
Completed |
Study Name: Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT Condition: Graft-Versus-Host Disease Date: 2014-05-13 Interventions: Drug: Cyclosporine Use of topical cyclosporine (one drop of cyclosporine in each eye, twice a day for 12 |
Recruiting |
Study Name: An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease Condition: Chronic Graft-versus-Host-Disease Oral Mucosal Disease Due to Date: 2014-04-23 Interventions: Drug: Sirolimus Other Name: Rapamune® |
Recruiting |
Study Name: Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease Condition: Graft -Versus-host-disease Date: 2014-02-04 Interventions: Biological: Mesenchymal stromal cells Allogenous mesenchymal stromal cells will be injected directly und |
Terminated |
Study Name: A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients Condition: Graft vs Host Disease Date: 2013-10-23 Interventions: Drug: ASEDs Experimental Inter |